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1. Introduction
  Plant-based immunomodulators draw many attentions 
and are investigated for immune modulating activity. Many 
natural plant products and their derived compounds have 
been evaluated for their potential to stimulate immune 
responses[1]. Medicinal plants become an indispensable 
part of standard health care, based on combination of 
long-time traditional usage and scientific research. 
Currently many groups reported the effects of plant-derived 
polysaccharides on the macrophage activation. Many 
research groups suggest that the majority of polysaccharides 
extracted from higher plants, mushrooms and algae 
enhance host defensive immune responses and promote 
immunomodulatory, anti-tumorigenic and other therapeutic 
effects through macrophages[1]. They are promising 
candidates as immunomodulators with no significant side 
effects[2]. Polysaccharides from medicinal plants exhibit 
numerous beneficial therapeutic 
properties, which presumably are due to the modulation 
of innate immunity and macrophage function[3,4]. Overall, 
the primary activity of botanical polysaccharides is to 
enhance or activate macrophage immune responses, 
leading to immunomodulatory activity[5]. Numerous dietary 
polysaccharides, including acidic polysaccharides, appear 
to possess diverse immunomodulatory activities in various 
types of animal tissues, including the blood, GI tract and 
spleen[6]. 
  Basella rubra (B. rubra) is a perennial herb and distributed 
throughout India. It is named as Ceylon spinach, climbing 
spinach, gui, acelga trepadora, bretana, libato, vine spinach, 
and Malabar nightshade. In Ayurveda and Folkloric 
medicine, B. rubra L. (Basellaceae) has been used for 
treating hemorrhages, skin diseases, and sexual weakness 
and relieving constipation[7,8]. In Chinese traditional 
medicine, the leaves or the aerial parts of B. rubra have 
been used as relieving constipation and also as a diuretic, 
a toxicide, and an anti-inflammatory agent[7,9]. The leaves, 
stems, and young shoot with buds of Basellaceae plant, B. 
rubra L. (Indian spinach) are consumed as a vegetable and 
health food. BRP-4, isolated from B. rubra L., is native 
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pectin-type polysaccharides, containing a backbone in 
which homogalacturonan (HG) regions of -(1→4)-linked 
D-Gal residues are interrupted by rhamnogalacturonan type 
I (RG-I) regions consisting of -(1→4)-linked D-galacturonic 
acid (GalA) residues[10].
  Recently, BRP-4 from B. rubra was reported to exhibit 
anti-HSV-2 activity in vivo [11]. However, relevant 
experimental work on the immune stimulatory activity of 
polysaccharides (BRP-4) isolated from B. rubra has not 
yet been explored. Most of the medicinal food ingredients 
promote cellular immune responses by increasing 
lymphocyte proliferation[12] and enhancing macrophage 
activities[13]. In this study, we investigated the immune 
stimulatory effect of polysaccharides (BRP-4) from B. rubra 
on macrophage activity and splenocyte proliferation.
2. Materials and methods
2.1. Chemicals and materials 
  Dulbecco’s Modified Eagle’s Media (DMEM), fetal bovine 
serum (FBS) (Gibco/Invitrogen, Carlsbad, CA, USA), 
Phagocytosis Assay Kit (IgG FITC) (Cayman Chemical 
Company, Ann Arbor, MI, USA). BRP-4 was kindly provided 
by Dr. Hayashi’s group[10]. 
2.2. Cell culture
  RAW264.7 murine macrophage cells (TIB71) were obtained 
from the American Type Culture Collection (Manassa, VA). 
Each cell line was cultured in Dulbecco’s Modified Eagle’s 
Media (DMEM; Gibco/Invitrogen, Carlsbad, CA, USA), as 
previously described[14].
2.3. Determination of nitric oxide 
  Nitric oxide production was determined as previously 
described[15] with slight modification. RAW264.7 cells (2×105 
cells/mL) were cultured in 48-well plates and incubated 
in the absence or presence with various concentrations (0, 
1, 10 and 100 g/mL) of BRP-4. After 20 h incubation, 100 L
of the culture medium was mixed with 100 L of Griess 
reagent (1% sulfanilamide in 5% phosphoric acid and 0.1% 
naphthylethylenediamine dihydrochloride in water) at room 
temperature for 10 min. The absorbance at 540 nm was then 
determined using a microplate reader (Tecan, Männedorf, 
Switzerland).
2.4. Fluorescent microscopy 
  Phagocytosis was identified by the Latex Beads-Rabbit 
IgG-FITC Solution, using the Phagocytosis assay kit (Cayman 
Chemical Company, Ann Arbor, MI, U.S.A.). RAW264.7 cells 
(1×105 cells/well) were grown on 48-well culture plates. 
RAW264.7 cells were treated with BRP-4 (0, 1, and 10 g/mL) 
and then added the Latex Beads-Rabbit IgG-FITC Solution. 
After 20 h incubation, cells were observed under an inverted 
fluorescence microscope with eGFP filter (Carl Zeiss, 
Göttingen, Germany).
2.5. Flow cytometry analysis 
  RAW264.7 cells (5×105 cells/well) grown on 12-well culture 
plates, incubated in the absence or presence of BRP-4 and 
then added the Latex Beads-Rabbit IgG-FITC Solution. 
After harvesting cells, the FITC dextran internalized cells 
was analyzed by a flow cytometer (FACS calibur, Becton 
Dickinson) and expressed as mean fluorescence intensity 
(MFI). 
2.6. Experimental animals for primary splenocytes 
  BALB/c mice (female, adult) were purchased from the 
Laboratory Animal Center, College of Medicine, National 
Taiwan University and maintained in the Department 
of Biochemical Science and Technology, College of Life 
Science, National Taiwan University. The mice were housed 
and fed a standard Lab diet (normal chow diet) individually. 
The animal room was kept on a 12-h-light and 12-h-dark 
cycle. Constant temperature (25依2) 曟 and humidity were 
maintained. The animals (8- to 10-week old) were sacrificed 
using CO2 inhalation to obtain spleens. The abdominal 
cavities were opened aseptically and the spleens were 
removed
2.7. Splenocyte proliferation assay
  The spleen cell proliferation response was assayed as 
described previously[16]. Briefly, spleens were removed 
aseptically from BALB/c mice. Splenocytes were prepared 
by lysing the red blood cells. Splenocyte proliferation was 
determined using the method as described by Sun et al[17] 
with some modifications. Briefly, 100 毺L of splenocytes at
5×105 cells/mL was seeded in triplicate in 96-well microtiter 
plates, thereafter concanavalin (Con) A (final concentration
3 毺g/mL), or medium was added giving a final volume 
of 200 毺L. After 30 min incubation of Con A, cells were 
incubated with BRP-4 (1 毺g/mL) for 48 h. Then, 10 毺L of 
CCK-8 was added to each well and incubated for further 4 h. 
The absorbance was evaluated in an ELISA reader at 570 nm 
with a 630 nm reference. 
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2.8. Statistical analysis 
  Results are expressed as mean依standard deviation (SD). 
Student’s t test or One-way ANOVA/Dunnett’s t test was 
used for assessment of significance between controls and 
treatments. Statistical analysis was performed using SPSS, 
version 12 (SPSS Inc., Chicago, IL, USA).
3. Results 
3.1. Effect of BRP-4 on the NO production in macrophages
  RAW264.7 cell line is commonly used in studies of innate 
immune responses to pathogens[18]. NO is a major mediator 
of macrophages, which acts as a destroyer to bacteria and 
tumor cells[19]. To determine the activity of macrophages, the 
production of NO was measured from the cell supernatant 
after stimulating the macrophages with BRP-4. The levels 
of NO were significantly increased in BRP-4 treated 
RAW264.7 cells (Figure 1). To rule out the possibility of LPS 
contamination during the purification process, we examined 
the effect of BRP-4 in the presence of polymyxin B, which 
neutralizes LPS activities on NO production. Polymyxin B 
treatment inhibited LPS-induced NO production but not 
BRP-4 induced NO production (data not shown). Thus, the 
activity of BRP-4 is not due to the LPS contamination.
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Figure 1. Effect of BRP-4 on the nitric oxide production in 
RAW264.7 cells. 
The culture supernatant was collected to measure the NO production 
with Griess reagent. One-way ANOVA was used for comparisons 
of multiple group means followed by Dunnett’s t-test (*P<0.05, 
**P<0.01, ***P< 0.001 vs. control).
3.2. Effect of BRP-4 on phagocytosis activities of 
macrophages 
  Macrophages are considered as the pivotal immunocytes of 
the host defense. In general, macrophage functions involve 
phagocytosis of antigens, microorganisms and cellular 
debris, and killing of invading microorganisms and tumors. 
To determine if BRP-4 activates immune function, we 
measured the phagocytic activity of RAW264.7 cells. The 
phagocytic activity of BRP-4 on macrophage phagocytosis 
were tested by phagocytosing FITC-expressing (i.e., 
fluorescence) latex bead. As shown in Figure 2a, BRP-4 
treated macrophages internalized much larger numbers of 
IgG FITC fluorescent latex beads than did untreated cells. 
Figure 2b and 2c indicate that phagocytosis increased in 
a dose dependent manner when incubated with BRP-4. 
These results indicate that BRP-4 stimulates the phagocytic 
activity against IgG-opsonized particles.
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Figure 2. Effects of BRP-4 on phagocytosis in RAW264.7 cells. 
(a) Phagocytosis of RAW264.7 cells to the FITC-labeled latex beads 
was examined after being treated with BRP-4 (0, 1, and 10 g/mL) 
for 20 h. Figure shown is one representative of three independent 
experiments (magnification, 100×) under phase-contrast microscopy. 
(b) Phagocytosis assays were performed after staining of RAW264.7 
cells with IgG FITC fluorescent latex beads at the time of opsonization 
and then subjected to flow cytometric analysis. The histogram overlays 
are labeled as follows: dot lines, unlabeled cells; gray line, labeled 
cell in the presence of vehicle (FITC labeled control). Results shown 
are representative of three experiments. (c) Values were quantified 
as mean fluorescence intensity (MFI) by flow cytometry. One-way 
ANOVA was used for comparisons of multiple group means followed 
by Dunnett’s t-test (*P<0.05, **P<0.01, ***P<0.001 vs. FITC 
labeled control).
3.3. Effect of BRP-4 on splenocyte proliferation
  Effects of BRP-4 on splenocyte proliferation with mitogen 
(Con A) and without mitogen were shown in Figure 3. BRP-4 
significantly improved the effect of splenocyte proliferation. 
After exposure to Con A, BRP-4-treated splenocyte showed 
significantly higher levels of stimulated proliferation of 
splenocytes than those in the control group or Con-A group 
(P<0.05 or P<0.01). BRP-4 combined with Con A significantly 
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promoted and strengthened the proliferation of the 
splenocytes (Figure 3). The present assay showed that BRP-4 
could significantly promote the Con A stimulated splenocyte 
proliferation, which could significantly increase or restore 
lymphocyte proliferation potential.
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Figure 3. Effects of BRP-4 on proliferation of splenocytes. 
Splenocytes were treated with BRP-4 (0 and 1 g/mL) for 48 h after 
30min treatment of ConA (3 g/mL) or vehicle. Primary splenocyte 
proliferation was assessed using CCK-8 assays. One-way ANOVA 
was used for comparisons of multiple group means followed by 
Dunnett’s t-test (*P<0.05, **P<0.01, ***P<0.001 vs. vehicle treated 
control, #P<0.001 vs. ConA treated control).
4. Discussion
  Polysaccharides from medicinal plants exhibit numerous 
beneficial therapeutic properties, which presumably are 
due to the modulation of innate immunity and macrophage 
function[3,4]. Overall, the primary activity of botanical 
polysaccharides is to enhance or activate macrophage 
immune responses, leading to immunomodulatory 
activity[5]. Numerous dietary polysaccharides, including 
acidic polysaccharides, appear to possess diverse 
immunomodulatory activities in various types of animal 
tissues, including the blood, GI tract and spleen[6]. Thus, 
we evaluated novel BRP-4, polysaccharides from B. rubra 
that might provide a unique opportunity for the discovery 
of novel therapeutic agents or adjuvants that exhibit 
immunomodulatory activities. 
  Macrophages function as ‘pathogen sensors’ and performs 
variety of biological activities, including phagocytosis, 
chemotaxis, destroying invading pathogens or tumor cells, 
regulation of the adaptive immune response, and repair of 
damaged tissue. Activated macrophages markedly enhanced 
ability to kill and degrade intracellular microorganisms[20]. 
This killing is caused by an increase of the inducible NO 
synthase (iNOS) gene to produce NO. It is reported that 
the amount of NO production by macrophages from old 
rats in response to Con A decreases compared with that of 
young rats[21]. Macrophages exhibits cytotoxicity through 
phagocytosis[1]. They can also function as antigen-presenting 
cells and can interact with T lymphocytes to modulate the 
adaptive immune response[22]. Activated macrophages not 
only participate in both specific and non-specific immune 
reactions, but also is the “bridge cell” of these two immune 
reactions[23]. 
  Many studies demonstrated that polysaccharides isolated 
from medicinal plants or food increased macrophage 
cytotoxic activity against tumor cells and microorganisms, 
activated phagocytic activity, increased reactive oxygen 
species (ROS) and nitric oxide (NO) production, and 
enhanced the production of cytokines and chemokines, 
including tumor necrosis factor (TNF-毩), interleukin (IL)-1, 
IL-6, IL-8, IL-12. Previously our group demonstrated that an 
acidic polysaccharide (APS) was isolated from the extract of 
Cordyceps militaris grown on germinated soybeans exhibited 
anti-influenza virus A activity and induce macrophage 
activation through promoting NO production and cytokine 
mRNA expression in macrophages[24]. Recently, BRP-4 
from B. rubra was reported to exhibit anti-HSV-2 activity 
in vivo[11]. Similarly, we observed that BRP-4 stimulated 
NO production in RAW264.7 cells. The present study 
investigated the phagocytic activity of murine macrophages. 
The phagocytic activity of macrophage was enhanced in 
BRP-4 treated RAW264.7 cells. 
  Lymphocyte proliferation is a crucial event in the activation 
cascade of both cellular and humoral immune responses[25]. 
Lymphocytes induced by ConA in vitro may be used as 
a method to evaluate T lymphocyte activity[25]. BRP-4 
showed a definite and clear synergistic effect on splenocyte 
proliferation after combining with Con A. It was indicated 
that BRP-4 could significantly increase the activate 
potential of T cells. However, the detailed mechanism of its 
action remained unclear. 
  In summary, BRP-4 exhibited potent immunopotentiation 
properties, such as enhancing the phagocytic activity 
of macrophages and elevating NO production. The 
splenocyte proliferation was also promoted by BRP-4. Our 
investigations suggested that BRP-4, polysaccharide from 
B. rubra, has the beneficial effect on immunostimulation. 
This study may provide an opportunity for developing 
BRP-4 as an ingredient of functional food and a potential 
alternative medicine.
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